Kyto Technology And Life Science Inc (KBPH) Return on Investment ROI from the third quarter of 2022 to third quarter of 2021 and for the year 2022, average high and low, overall ranking from Dec 31 2021 to Dec 31 2020 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Kyto Technology And Life Science Inc   (KBPH)


Kyto Technology And Life Science Inc's ROI from its third quarter of 2022 to the third quarter of 2021 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Kyto Technology And Life Science Inc's ROI in the third quarter of 2022?
Kyto Technology And Life Science Inc achieved a return on average invested assets (ROI) of 11.51 % in its third quarter of 2022, this is above KBPH's average return on investment of -11.47%.
Kyto Technology And Life Science Inc invested over the 12 months ending in its third quarter of 2022 $10 million

Despite the deterioration in its net income, company has improved ROI compared to the second quarter of 2022.

Within the Healthcare sector 104 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Dec 31 2021 quarter, so far to 805, from total ROI ranking in the second quarter of 2022 at 1316.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
III. Quarter		 (Sep 30 2021)
II. Quarter		 (Jun 30 2021)
I. Quarter		 (Mar 31 2021)
IV. Quarter		 (Dec 31 2020)
III. Quarter
Y / Y Investment Change TTM 141.79 % 157.97 % 137.68 % 101.07 % 78.06 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 13 11 9 7 6
Return On Investment (TTM) 11.51 % 9.85 % 2.01 % 8.28 % -2.11 %
KBPH's Overall Ranking # 805 # 1316 # 2364 # 1284 # 0
Seq. Investment Change TTM 19.79 % 25.44 % 27.17 % 26.53 % 27.81 %
Seq. Net Income Change TTM 40.01 % 513.08 % -69.06 % - -
Net Income (TTM) in Millions 1 1 0 0 0

KBPH Company Profile >> Back to KBPH Roi Comparisons >> See Annual KBPH Return On Investment



Return On Investment KBPH's Ranking
Within: No.
Industry # 47
Sector # 105
Overall # 805

Return On Investment Statistics
High Average Low
13.79 %
-11.47 %
-30.15 %
(Dec 31 2021)   (Mar 31 2020)







Financial Statements
Kyto Technology And Life Science Inc's III. Quarter Investments $ 13 Millions KBPH's Balance sheet
Kyto Technology And Life Science Inc's III. Quarter Income $ 0 Millions Quarterly KBPH's Income Statement
KBPH's Income by Division See KBPH's Income by Division


KBPH Annual Return On Investment (Mar 31 2021)
2021		 (Mar 31 2020)
2020		 (Mar 31 2019)
2019

Total Investments in Millions 7 3 2 0 0
Y / Y Investment Growth 162.15 % 70.6 % - - -
Net Income in Millions 0 -1 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 6.11 % -28.99 % -14.72 % - -


Annual Roi Comment
In the fiscal year 2021 ROI improved to 6.11 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
KBPH's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for KBPH's Competitors
Subscribers only: Roi for Kyto Technology And Life Science Inc's Suppliers
Subscribers only: Return On Investment for KBPH's Customers

Other Ratios
KBPH's Roa KBPH's Inventory Turnover Ratio KBPH's Growth Rates KBPH's Dividend Statistics
KBPH's Profitability Ratios KBPH's Asset Turnover Ratio KBPH's Dividend Growth
KBPH's Roe KBPH's Valuation Ratios KBPH's Financial Strength Ratios KBPH's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI
Genfit S a   30.73 %
Progyny Inc   29.29 %
Antares Pharma Inc   28.50 %
Incyte Corporation  27.46 %
West Pharmaceutical Services Inc   26.42 %
Bio rad Laboratories Inc   26.15 %
Elite Pharmaceuticals Inc   25.11 %
Sunlink Health Systems Inc   24.91 %
Sonida Senior Living Inc   24.82 %
Exelixis Inc   24.58 %
La Jolla Pharmaceutical Company  23.85 %
Chemed Corporation  23.34 %
Corcept Therapeutics Inc  23.06 %
Hologic Inc  22.69 %
Vertex Pharmaceuticals Inc  22.02 %
Tivity Health Inc   21.97 %
Edwards Lifesciences Corporation  21.86 %
Zynex inc   20.95 %
Align Technology inc   20.34 %
Lftd Partners Inc   20.12 %
Catalyst Pharmaceuticals Inc   20.01 %
Maravai Lifesciences Holdings Inc   19.66 %
Atea Pharmaceuticals Inc   19.53 %
Novo Nordisk A  18.97 %
Lifevantage Corp  18.81 %
Sensus Healthcare Inc   18.28 %
Novartis Ag  18.26 %
Waters Corporation  18.12 %
Dynavax Technologies Corporation  18.08 %
Merck and Co Inc   18.00 %

Date modified: 2022-03-01T22:51:15+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.